Isolated, reduced diffusing capacity for carbon monoxide in the population: relations to symptoms, smoking and comorbiditiesDepartment of Radiology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden; Department of Radiology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden; Department of Clinical Physiology in Linköping, Region Östergötland, Linköping, Sweden.
Respiratory Medicine, Allergology, and Palliative Medicine, Department of Clinical Sciences Lund, Lund University and Skåne University Hospital, Lund, Sweden.
Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.
Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden; Faculty of Medicine, Reykjavik and Department of Respiratory Medicine, University of Iceland, Landspitali University Hospital, Reykjavik, Iceland.
Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden; Department of Clinical Physiology, Karolinska University Hospital, Stockholm, Sweden.
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine.
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.
Division of Immunology and Respiratory Medicine, Department of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden.
Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden; Department of Respiratory Medicine in Linköping, Linköping University, Linköping, Sweden.
Division of Immunology and Respiratory Medicine, Department of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden.
Division of Immunology and Respiratory Medicine, Department of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden.
Umeå University, Faculty of Medicine, Department of Diagnostics and Intervention.
Department of Medicine, Skåne University Hospital, Lund University, Lund, Sweden.
Section of Occupational and Environmental Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Occupational and Environmental Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Internal Medicine and Clinical Nutrition, COPD Center, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Translational Medicine, Lund University, Malmö, Sweden.
Department of Medical Sciences, Clinical Physiology, Uppsala University, Uppsala, Sweden.
Show others and affiliations
2026 (English)In: BMC Pulmonary Medicine, E-ISSN 1471-2466, Vol. 26, no 1, article id 387
Article in journal (Refereed) Published
Abstract [en]
Background: Diffusing capacity for carbon monoxide (DLCO) is a measure of gas exchange in the lungs. Reduced DLCO with normal spirometry is a common finding that is incompletely understood.
Aim: To assess determinants of isolated, reduced DLCO in an unselected population.
Methods: The Swedish CArdioPulmonary bioImage Study (SCAPIS) is a multicentre population-based study of adults aged 50–64 years. The 5th percentile of DLCO in healthy never smokers was used as the lower limit of normal (LLN). Using multivariable analysis, we studied factors associated with DLCO < LLN in 24 261 subjects with normal spirometry, defined as FEV1, FVC and FEV1/FVC > LLN. Emphysema and interstitial lung abnormalities (ILA) were assessed through computed tomography, physical activity through accelerometry and other factors through questionnaires.
Results: Isolated DLCO < LLN (n = 1 472) was independently associated with emphysema (odds ratio and 95% confidence interval: 2.6 (2.2, 3.2)), lung disease other than asthma or COPD (1.8 (1.2, 2.8)), exertional chest pain (1.6 (1.3, 2.1)), smoking (per-10-pack-years) (1.6 (1.4, 1.9)), ILA (1.4 (1.2, 1.7)), breathing problems (1.4 (1.1, 1.8)), male sex (1.3 (1.1, 1.6)) and coughing (1.2 (1.1, 1.5)). DLCO < LLN was less likely if subjects were older, had asthma or had higher BMI, haemoglobin, FVC or physical activity.
Conclusion: Isolated, reduced DLCO in a large middle-aged population cohort is associated with numerous previously known factors, including emphysema, ILA, smoking and self-reported lung disease. However, several symptoms, including exertional chest pain, breathing problems and coughing, are also independently associated with isolated reduced DLCO.
Place, publisher, year, edition, pages
Springer Nature, 2026. Vol. 26, no 1, article id 387
Keywords [en]
Diffusion capacity for carbon monoxide, Emphysema, General population, Lung function, Smoking
National Category
Respiratory Medicine and Allergy
Identifiers
URN: urn:nbn:se:umu:diva-258969DOI: 10.1186/s12890-026-04662-9ISI: 001864175000001PubMedID: 42675482Scopus ID: 2-s2.0-105048893014OAI: oai:DiVA.org:umu-258969DiVA, id: diva2:2102856
Funder
Lund UniversitySwedish Heart Lung Foundation, 20210365Swedish Heart Lung Foundation, 202305872026-09-182026-09-182026-09-18Bibliographically approved